Scarica l'app Stockscreener
348.12
2.51%
8.53
Dopo l'orario di chiusura:
352.84
4.72
+1.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$339.59
Aprire:
$342.12
Volume 24 ore:
1.51M
Relative Volume:
0.96
Capitalizzazione di mercato:
$134.90B
Reddito:
$22.60B
Utile/perdita netta:
$2.99B
Rapporto P/E:
44.86
EPS:
7.76
Flusso di cassa netto:
$3.49B
1 W Prestazione:
+0.38%
1M Prestazione:
-6.19%
6M Prestazione:
-4.89%
1 anno Prestazione:
+6.24%
Intervallo 1D:
$341.51
$349.45
Intervallo di 1 settimana:
$335.12
$352.58
Portata 52W:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 389-2600
Indirizzo
2825 AIRVIEW BLVD, KALAMAZOO, MI
Confronta SYK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Citigroup | Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
Paul Harris' Past Picks: Stryker, Essilor Luxottica & Novo Nordisk - BNN Bloomberg
TD Cowen maintains Stryker stock Buy rating, $435 target - Investing.com
Stryker accuses German rival Fiagon of patent infringement at USITC - MLex
Stryker Corporation (SYK): A Bull Case Theory - MSN
Here's What to Expect From Stryker Corporation's Next Earnings Report - Nasdaq
Here's What To Expect From Stryker Corporation's Next Earnings Report - Barchart.com
Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents - Law360
Federal Circuit Axes Stryker Unit’s Sterilized Wipe Patents - Bloomberg Law News
The Zacks Analyst Blog Bank of America, Chevron, Stryker, Value Line and Sypris - Yahoo Finance
Stryker (SYK): BTIG Analyst Revises Price Target Amid MedTech Ou - GuruFocus
Top Analyst Reports for Bank of America, Chevron & Stryker - Yahoo Finance
Meritage Homes, TopBuild, Installed Building Products, Champion Homes, and Stryker Shares Plummet, What You Need To Know - Yahoo Finance
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
What Does the Market Think About Stryker? - Benzinga
Teledyne Technologies Awarded Four-Year, $74 Million US Army Contract to Upgrade Stryker Sensors - MarketScreener
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Stryker (SYK): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Stryker to announce financial results for its first quarter of fiscal year 2025 - MarketScreener
Mark Your Calendar: Stryker's Q1 2025 Earnings Release Coming May 1 - Stock Titan
Stryker Corporation : INVESTOR ALERTPATIENT SAFETY TECHNOLOGIES, INC. - MarketScreener
Activist shareholder renews push for Stryker to reveal political contributions - Crain's Grand Rapids Business
Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha
Pictet Asset Management Holding SA Cuts Stock Position in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker completes sale of U.S. spinal implants business - Ortho Spine News
Evercore ISI Adjusts Stryker Price Target to $400 From $410, Maintains Outperform Rating - MarketScreener
Stryker (SYK): Company Profile, Stock Price, News, Rankings - Fortune
Stryker : 2024 Comprehensive Report - MarketScreener
Stryker Closes Sale of US Spinal Implants Unit to Vascogliosi Brothers - MarketScreener
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - Yahoo Finance
Stryker sells US spinal implants business to VB Spine - Investing.com
Stryker Completes Sale Of U.S. Spinal Implants Business - MarketScreener
Stryker Co. (NYSE:SYK) Shares Sold by Franklin Resources Inc. - MarketBeat
Stryker Corporation (NYSE:SYK): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
Stocks With Rising Relative Strength: Stryker - MSN
California Public Employees Retirement System Raises Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corporation (SYK): Jim Cramer Sees Big Gains Despite Tariff Worries - Insider Monkey
Ex-Dividend Reminder: Stryker, Innovative Industrial Properties and Apple Hospitality REIT - Nasdaq
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock - Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment - Benzinga
Stryker increases pay for top execs, reports slightly lower wage for median employee - Medical Design & Outsourcing
Stryker announces intention to nominate Manny Maceda to board of directors - Quantisnow
Stryker nominates new board member - Investing.com
Stryker nominates new board member By Investing.com - Investing.com Canada
Is It Smart To Buy Stryker Corporation (NYSE:SYK) Before It Goes Ex-Dividend? - Yahoo Finance
Stryker announces Annual Meeting of Shareholders - The Globe and Mail
Here's How Much $1000 Invested In Stryker 5 Years Ago Would Be Worth Today - Benzinga
Stryker Makes Shareholder Meeting Accessible: Virtual Format Opens Doors to All Investors - Stock Titan
What's Driving the Market Sentiment Around Stryker? - Benzinga
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):